
Build scalable obesity care with multidisciplinary teams, clear triage, and monitoring protocols; address GLP-1 gaps, Medicare access and price barriers, including oral GLP-1.
It was a historic week in the nation's capital as the Supreme Court heard oral arguments on four separate but intertwined issues regarding the constitutionality of the landmark Affordable Care Act (ACA). But that wasn't the only thing that happened in Washington this week: the House passed a budget bill that included substantial changes to the Medicare and Medicaid programs, and the FDA rejected a petition to ban the chemical bisphenol A, which is used in food packaging.
Read the full story:
Source: MedPage Today






